Educational Activities Archives

Unhealthy substance use and substance use disorders may often go unrecognized in primary care settings, either due to insufficient screening or provider discomfort with how to manage a positive screening. There are brief, simple, validated screening tools and strategies that can provide information to indicate unhealthy substance use or the possible presence of a substance use disorder. This information can inform providers whether a simple brief intervention or a referral to treatment is warranted. This course will: introduce screening tools for alcohol and other drug use; review more detailed substance use, medical, and psychiatric assessment considerations; demonstrate effective strategies for brief interventions; and discuss considerations for treatment referrals.

Co-occurring psychiatric conditions are frequently seen in patients with substance use disorders. Clinicians should be alert to the signs and symptoms of common psychiatric disorders and should understand how to distinguish independent psychiatric disorders from substance-induced disorders. Depressive disorders and anxiety disorders, including post-traumatic stress disorder, are the most common co-occurring conditions, though ADHD is often encountered across the range of substance use disorders. Substance use disorder patients with co-occurring psychiatric disorders will respond to most standard psychological and pharmacological treatments for these psychiatric conditions, though clinicians should avoid the use of scheduled medications and must always focus on sobriety as a primary treatment goal. Treatment that integrates addiction and psychiatric care is the most effective.

This activity focuses on the assessment, mitigation and management of risk when prescribing opioids for analgesia. Learners are introduced to the concept of universal precautions and their role in opioid therapy, as well as to practical monitoring and documentation strategies. The fundamental principles of urine drug testing and interpretation are also reviewed, as is the differential diagnosis of opioid misuse. Special attention is given to overdose prevention, naloxone co-prescribing, and how to recognize and respond to an emerging opioid use disorder when prescribing chronic opioid therapy for pain.

Due to the opioid epidemic, over 2.5 million adults in the U.S. have opioid use disorder (OUD), yet only 25% of those who need treatment receive recommended medication for opioid use disorder (MOUD). Alongside the rising rates of OUD, there has been an increase in infectious diseases such as HIV, hepatitis B and C, endocarditis and skin and soft-tissue infections, particularly among people who inject drugs. These intertwining epidemics have not been sufficiently addressed, but MOUD — combined with appropriate substance use treatment supports and health care services — represents an opportunity to reduce risk and improve health outcomes.

Provides a basic introduction of the concepts of the disease of addiction and the role of the reward system. Using neuroscience concepts as a foundation, clinical manifestations of the disease of addiction are then discussed in the form of case-based presentations. 

Outlines the basic concepts of alcohol and drug use disorders. Standard drink sizes, screening for alcohol use disorders and an introduction to alcohol withdrawal management are discussed. A basic overview of the major drug use disorders are then discussed in a clinically-relevant manner.